Showing 64,781 - 64,800 results of 122,698 for search '(( 2 e decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.44s Refine Results
  1. 64781

    Supplementary Material for: Incidence and Importance of Calcium Deposition in Kidney Biopsy Specimens by Gaddy A. (13140000)

    Published 2022
    “…Patients with calcium oxalate deposition alone, compared to calcium phosphate or mixed calcifications, had fewer comorbidities but were more likely to have a history of gastric bypass surgery or malabsorption and take vitamin D. In patients with two or more years of follow-up, multivariate analyses showed the presence of calcification (HR 0.59, 0.38–0.92, <i>p</i> = 0.02) and higher eGFR (HR 0.76, 0.73–0.79, <i>p</i> < 0.001), was associated with decreased likelihood of progressing to end-stage renal disease. …”
  2. 64782

    Data_Sheet_1_Identification of Halloween Genes and RNA Interference-Mediated Functional Characterization of a Halloween Gene shadow in Plutella xylostella.PDF by Lu Peng (769036)

    Published 2019
    “…RNAi-based knockdown of sad, which is involved in the last step of ecdysone biosynthesis, significantly reduced the 20E titer and resulted in a longer developmental duration and lower pupation of fourth-instar larvae, as well as caused shorter ovarioles and fewer fully developed eggs of P. xylostella. …”
  3. 64783
  4. 64784
  5. 64785

    Data Sheet 2_Bevacizumab and anlotinib combination therapy acts via HIF-1α suppression to exert synergistic anti-angiogenic and anti-tumor effects in non-small cell lung cancer.pdf... by Nafeisha Simayi (22262161)

    Published 2025
    “…B+A inhibited cell viability by 78%, colony formation by 90%, and invasion by 75% in NSCLC cell lines A549 and H1299; downregulated N-cadherin 5.34-fold, vimentin 6.46-fold, and α-SMA 4.35-fold; and upregulated E-cadherin 3.75-fold. …”
  6. 64786

    Image_1_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
  7. 64787

    Image_4_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
  8. 64788

    Image_6_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
  9. 64789

    Table_1_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.pdf by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
  10. 64790

    Image_2_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
  11. 64791

    Image_3_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
  12. 64792

    Table_1_Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patien... by Minghui Li (409892)

    Published 2022
    “…Objective<p>To explore dynamic changes of cytokines and virological markers associated with hepatitis B surface antigen (HBsAg) loss during peginterferon alpha-2a (PEG-IFN α-2a) treatment in hepatitis B e antigen (HBeAg) positive chronic hepatitis B (CHB) patients.…”
  13. 64793

    Table_3_Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patien... by Minghui Li (409892)

    Published 2022
    “…Objective<p>To explore dynamic changes of cytokines and virological markers associated with hepatitis B surface antigen (HBsAg) loss during peginterferon alpha-2a (PEG-IFN α-2a) treatment in hepatitis B e antigen (HBeAg) positive chronic hepatitis B (CHB) patients.…”
  14. 64794

    Metformin does not further increase the median lifespan of DR-constitutive mutant eat-2, and metformin treatment triggers several DR phenotypes in wild-type <i>C. elegans</i> witho... by Brian Onken (86790)

    Published 2010
    “…</b> Survival curves of <i>eat-2(ad1116)</i> mutants raised on 0 mM, 1 mM, 10 mM, and 50 mM metformin plates at 20°C. …”
  15. 64795

    Effects of Innexin knockdown with RNAi on the strength of the JON-GF connection. by Adeline P. Pézier (2600692)

    Published 2016
    “…Only for this innexin is there a significant decrease in the response of the GF, to SEP1 of greater than 0.2 mV and SEP2 greater than 0.4 mV. …”
  16. 64796
  17. 64797

    Table_1_Sepsis and delayed cerebral ischemia are associated and have a cumulative effect on poor functional outcome in aneurysmal subarachnoid hemorrhage.DOCX by Franz-Simon Centner (9354214)

    Published 2024
    “…Good functional outcome gradually decreased from 56.3% (76/135) in patients with neither sepsis nor DCI, to 43.8% (21/48) in those with no sepsis but DCI, to 34.5% (10/29) with sepsis but no DCI and to 7.7% (2/26) in patients with both sepsis and DCI.…”
  18. 64798

    Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector-3 by Hugo Peluffo (72772)

    Published 2011
    “…</p>suring the total climbing time until falling when placed on an inclinated grid (A); spontaneous turning behaviour in an open field (total turns recorded in 1.5 min.)…”
  19. 64799

    Presentation1_Body mass index is associated with pulmonary gas and blood distribution mismatch in COVID-19 acute respiratory failure. A physiological study.PPTX by Kristín J. Bjarnadóttir (19022189)

    Published 2024
    “…In morbidly obese patients, gas and blood were more evenly distributed; therefore, the mismatch was lower than in other patients (30% vs. 36%, p < 0.05). 3) An increase in BMI of 5 kg/m<sup>2</sup> was associated with a decrease in mismatch of 3.3% (CI: 3.67% to −2.93%, p < 0.05). …”
  20. 64800

    Image7_Investigating Effect of Coherent Emission Length on Pion Interferometry in High-Energy Collisions Using a Multiphase Transport Model.EPS by Shi-Yao Wang (12521500)

    Published 2022
    “…A coherent emission length is introduced, the effects of which on the two-pion interferometry results in central Au-Au collisions at sNN=200 GeV, central Pb-Pb collisions at sNN=2.76 TeV, and p-p collisions at s=13 TeV are investigated. …”